enkephalin, leucine has been researched along with fluphenazine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Austin, MC; Kalivas, PW | 1 |
Traficante, LJ; Turnbull, B | 1 |
Herman, ZS; Kowalski, J; Przewłocki, R; Trzeciak, H | 1 |
Furukawa, T; Yamada, K | 1 |
Aloyo, VJ; Chen, JF; Qin, ZH; Weiss, B | 1 |
Coirini, H; Johnson, AE; Källström, L; Wiesel, FA | 1 |
Churchill, L; Kalivas, PW; Klitenick, MA | 1 |
7 other study(ies) available for enkephalin, leucine and fluphenazine
Article | Year |
---|---|
Dopaminergic involvement in locomotion elicited from the ventral pallidum/substantia innominata.
Topics: Animals; Biogenic Amines; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Fluphenazine; Globus Pallidus; Haloperidol; Male; Motor Activity; Osmolar Concentration; Picrotoxin; Rats; Rats, Inbred Strains; Substantia Innominata | 1991 |
Neuropeptide degrading enzyme(s) in plasma and brain: effects of in vivo neuroleptic administration.
Topics: Aminopeptidases; Animals; Antidepressive Agents; Antipsychotic Agents; Brain; Chlorpromazine; Corpus Striatum; Endorphins; Enkephalins; Fluphenazine; Imipramine; In Vitro Techniques; Inactivation, Metabolic; Mice; Peptide Hydrolases | 1982 |
Enkephalin content in rat striatum during prolonged treatment with fluphenazine.
Topics: Animals; Apomorphine; Corpus Striatum; Enkephalin, Leucine; Enkephalin, Methionine; Enkephalins; Fluphenazine; Male; Naloxone; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1984 |
Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.
Topics: Aminooxyacetic Acid; Animals; Antiparkinson Agents; Catalepsy; Delayed-Action Preparations; Drug Synergism; Enkephalins; Fluphenazine; Haloperidol; Humans; Male; Mice; Mice, Inbred Strains; Receptors, Dopamine | 1982 |
Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum.
Topics: Animals; Base Sequence; Corpus Striatum; Dopamine D2 Receptor Antagonists; Enkephalins; Fluphenazine; Male; Molecular Sequence Data; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; RNA, Messenger | 1994 |
Modulation of basal ganglia neurotransmission by the classical antipsychotic fluphenazine is due in part to the blockade of dopamine D1-receptors.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Basal Ganglia; Benzazepines; Dopamine Antagonists; Enkephalins; Female; Fluphenazine; Glutamate Decarboxylase; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Synaptic Transmission; Transcription, Genetic | 1997 |
Dopamine depletion reorganizes projections from the nucleus accumbens and ventral pallidum that mediate opioid-induced motor activity.
Topics: Analgesics, Opioid; Animals; Baclofen; Dopamine; Dopamine Antagonists; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Fluphenazine; GABA Agonists; Globus Pallidus; Locomotion; Male; Microinjections; Motor Activity; Motor Neurons; Muscimol; Neural Pathways; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Sympatholytics | 1998 |